BACKGROUND AND PURPOSE: The self-expanding V-POD is a second-generation flow-diverting device with a low-porosity PTFE patch on a self-expanding microstent. The authors evaluated this device for the treatment of elastase-induced aneurysms in rabbits. MATERIALS AND METHODS: Three V-POD types (A, circumferential patch closed-cell stent [n = 9]; B, asymmetric patch closed-cell stent [n = 7]; and C, asymmetric patch open-cell stent [n = 4]) were evaluated by using angiography, conebeam micro-CT, histology, and SEM. Aneurysm flow modifications were expressed in terms of immediate poststent/prestent ratios of maximum CA volume entering the aneurysm dome tracked on procedural angiograms. Flow modifications were correlated with 4 weeks' follow-up angiographic, micro-CT, histologic, and SEM results. RESULTS: Mechanical stent-deployment difficulties in 4 aneurysms (1 type A; 3 type B) led to suboptimal results and exclusion from analysis. Of the remaining 16 aneurysms, 4-week post-treatment angiograms showed no aneurysm filling in 10 (63%), 3 (∼19%) had no filling with a small remnant neck, and 3 (∼19%) had <0.25 filling. Successfully treated aneurysms (n = 16) demonstrated an immediate poststent/prestent CA maximum volume ratio of 0.13 ± 0.18% (0.0%-0.5%). Favorable contrast-flow modification on immediate angiography after deployment correlated significantly with aneurysm occlusion on follow-up angiography, micro-CT, and histology. The occlusion percentage derived from micro-CT was 96 ± 6.8%. Histology indicated advanced healing (grade ≥3) in the aneurysm dome in 13 of 16 cases. SEM revealed 15 of 16 stents in an advanced state of endothelialization. CONCLUSIONS: This study showed the feasibility and effectiveness of V-POD for aneurysm healing in a rabbit elastase model.
BACKGROUND AND PURPOSE: The self-expanding V-POD is a second-generation flow-diverting device with a low-porosity PTFE patch on a self-expanding microstent. The authors evaluated this device for the treatment of elastase-induced aneurysms in rabbits. MATERIALS AND METHODS: Three V-POD types (A, circumferential patch closed-cell stent [n = 9]; B, asymmetric patch closed-cell stent [n = 7]; and C, asymmetric patch open-cell stent [n = 4]) were evaluated by using angiography, conebeam micro-CT, histology, and SEM. Aneurysm flow modifications were expressed in terms of immediate poststent/prestent ratios of maximum CA volume entering the aneurysm dome tracked on procedural angiograms. Flow modifications were correlated with 4 weeks' follow-up angiographic, micro-CT, histologic, and SEM results. RESULTS: Mechanical stent-deployment difficulties in 4 aneurysms (1 type A; 3 type B) led to suboptimal results and exclusion from analysis. Of the remaining 16 aneurysms, 4-week post-treatment angiograms showed no aneurysm filling in 10 (63%), 3 (∼19%) had no filling with a small remnant neck, and 3 (∼19%) had <0.25 filling. Successfully treated aneurysms (n = 16) demonstrated an immediate poststent/prestent CA maximum volume ratio of 0.13 ± 0.18% (0.0%-0.5%). Favorable contrast-flow modification on immediate angiography after deployment correlated significantly with aneurysm occlusion on follow-up angiography, micro-CT, and histology. The occlusion percentage derived from micro-CT was 96 ± 6.8%. Histology indicated advanced healing (grade ≥3) in the aneurysm dome in 13 of 16 cases. SEM revealed 15 of 16 stents in an advanced state of endothelialization. CONCLUSIONS: This study showed the feasibility and effectiveness of V-POD for aneurysm healing in a rabbit elastase model.
Authors: Ciprian N Ionita; Keneth R Hoffmann; Daniel R Bednarek; Ravishankar Chityala; Stephen Rudin Journal: J Digit Imaging Date: 2007-02-28 Impact factor: 4.056
Authors: Ciprian N Ionita; Himanshu Suri; Sabareesh Nataranjian; Adnan Siddiqui; Elad Levy; Nelson L Hopkins; Daniel R Bednarek; Stephen Rudin Journal: Proc SPIE Int Soc Opt Eng Date: 2011
Authors: David Fiorella; Felipe C Albuquerque; Vivek R Deshmukh; Henry H Woo; Peter A Rasmussen; Thomas J Masaryk; Cameron G McDougall Journal: Neurosurgery Date: 2006-08 Impact factor: 4.654
Authors: Zsolt Kulcsár; Ulrike Ernemann; Stephan G Wetzel; Alexander Bock; Sophia Goericke; Vasilis Panagiotopoulos; Michael Forsting; Daniel A Ruefenacht; Isabel Wanke Journal: Stroke Date: 2010-07-08 Impact factor: 7.914
Authors: I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson Journal: AJNR Am J Neuroradiol Date: 2010-02-11 Impact factor: 3.825
Authors: Juan R Cebral; Fernando Mut; Marcelo Raschi; Yong-Hong Ding; Ramanathan Kadirvel; David Kallmes Journal: Int J Numer Method Biomed Eng Date: 2014-04-09 Impact factor: 2.747
Authors: F Clarençon; F Di Maria; J Gabrieli; E Shotar; C Zeghal; A Nouet; J Chiras; N-A Sourour Journal: Clin Neuroradiol Date: 2015-08-07 Impact factor: 3.649
Authors: Ciprian N Ionita; Victor L Garcia; Daniel R Bednarek; Kenneth V Snyder; Adnan H Siddiqui; Elad I Levy; Stephen Rudin Journal: Proc SPIE Int Soc Opt Eng Date: 2014-03-13
Authors: Y Ding; D Dai; D F Kallmes; D Schroeder; C P Kealey; V Gupta; A D Johnson; R Kadirvel Journal: AJNR Am J Neuroradiol Date: 2015-10-22 Impact factor: 3.825
Authors: Kyle A Williams; Alexander R Podgorsak; Mohammad Mahdi Shiraz Bhurwani; Ryan A Rava; Kelsey N Sommer; Ciprian N Ionita Journal: Proc SPIE Int Soc Opt Eng Date: 2021-02-15